CDC Anthrax Researcher Resigns

The former head of a US Centers for Disease Control and Prevention biosecurity lab has left his post amidst safety retooling at government labs.

By | July 23, 2014

CDCMichael Farrell, the former head of the US Centers for Disease Control and Prevention (CDC) Bioterror Rapid Response and Advanced Technology Laboratory, who last month was reassigned in the wake of the biosecurity oversight that exposed agency scientists to anthrax, has now resigned. CDC spokesperson Thomas Skinner told The New York Times that Farrell’s resignation was voluntary. “It was his decision,” Skinner said.

Farrell led the Bioterror Rapid Response and Advanced Technology Laboratory, which handles potentially dangerous materials including pathogens like Bacillus anthracis, since 2009. As The Guardian pointed out, Farrell is the first government employee to leave his post following a string of lab safety mishaps that have led to increased scrutiny.

In media interviews, Sean Kaufman, a former CDC employee who’s now president of the consulting firm Behavioral-Based Improvement Solutions, defended Farrell. “He’s a scapegoat and everybody knows that,” Kaufman, who was asked to testify at last week’s House hearing on biosecurity issues in government labs, told USA Today. “For [Farrell] to resign as a result of this is an indicator that they’re focusing on who instead of what. It was a culture that led to this issue. It was not an individual,” he told Reuters.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Rethinking the Rise of Mammals
    Daily News Rethinking the Rise of Mammals

    Mammals diversified 30 million years later than previously estimated, according to a new analysis of an ancient fossil.

  2. Wiping Out Gut Bugs Stops Obesity
  3. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  4. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

Life Technologies